Affiliation:
1. Department of Neurosurgery, The Fourth Affiliated Hospital
2. Department of Neurosurgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China
Abstract
A 40-year-old man presented with acromegaly, reduction of visual acuity and visual field, and elevated blood sugar. Imaging examinations demonstrated a large sellar adenoma with suprasellar extension that compresses the optic chiasma upward, spreads downward to the sphenoid sinus, and invades the cavernous sinus bilaterally. Random prolactin and growth hormone were beyond the scope of normal. The patient achieved complete shrinking of the adenoma by taking bromocriptine orally. For some kinds of giant mixed growth hormone-prolactin adenomas, surgical treatment is not necessary, and drug treatment can also achieve good results.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference7 articles.
1. Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal;Sadoul;Acta Endocrinol (Copenh),1992
2. Clinical-pathological correlations of pituitary tumours;Thapar;Baillieres Clin Endocrinol Metab,1995
3. Overview of the 2022 WHO classification of pituitary tumors;Asa;Endocr Pathol,2022
4. An update on pituitary neuroendocrine tumors leading to acromegaly and gigantism;Asa;J Clin Med,2021
5. Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: a retrospective study with long-term follow-up;Lv;Endocrine,2019